Stroke rehab boost: exercise plus Self-Management may keep patients moving

NCT ID NCT02951338

Terminated Symptom relief Sponsor: Toronto Rehabilitation Institute Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a program called PROPEL that combines group aerobic exercise with weekly self-management discussions for people recovering from a stroke. The goal was to see if this approach helps participants stay physically active for six months after leaving rehabilitation. The trial enrolled 57 people across six hospitals, but it was terminated early, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PROPEL program (group aerobic exercise plus self-management discussions)
What this could lead to: If successful, this approach could help stroke survivors stay more active after rehab, improving recovery and reducing the risk of another stroke.
What could go wrong: The trial was terminated early with only 57 participants, so results are limited. It is unclear if the program works better than exercise alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STROKE

Contacts and locations

Locations

Hamilton Health Sciences

Hamilton, Ontario, L8L 2X2, Canada
St. Joseph's Care Group

Thunder Bay, Ontario, P7B 5G7, Canada
Sunnybrook Research Institute

Toronto, Ontario, M4N 3M5, Canada
Toronto Rehabilitation Institute - UHN

Toronto, Ontario, M5G 2A2, Canada
West Park Healthcare Centre

Toronto, Ontario, M5G 1V7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.